Moderna ($MRNA) steps into Thursday’s analyst day with more pressure than momentum. The stock is down more than 40% this year ...

The UK is launching a groundbreaking Horizon trial to see if a vaccine can help people with multiple sclerosis by targeting ...

A clinical trial testing an experimental vaccine for the Epstein-Barr virus (EBV) in people with MS is now recruiting ...

Public health researchers found no uptick in myositis associated with COVID-19 vaccines across Norway and Sweden in a controlled study, contradicting previous reports of the condition occurring in the ...

Johnson & Johnson entered into a definitive agreement to acquire Halda Therapeutics OpCo for $3.05 billion in cash. Eli Lilly announced it will pay $40 million upfront and up to $2.56 billion in a ...

A new trial will test whether a jab to protect against a common virus found in almost all people with multiple sclerosis (MS) ...

A quarter of Metagenomi’s employees, including the company’s CEO, are set to lose their jobs after the gene editing biotech ...

Have you seen ads for the new low-dose COVID vaccine called mNEXSpike and wondered what it's all about? Us too! So we did ...

A groundbreaking new trial is set to investigate whether an mRNA jab, designed to target the Epstein-Barr virus (EBV), could ...

Agentic AI isn’t your humdrum chatbot anymore: it’s autonomous decision-making algorithm that lives in workflows, interacts ...